Krebs Biochemicals & Industries Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 12.94 | 12.92 | 12.18 |
| Operating Expense | 15.57 | 15.09 | 15.09 |
| Net Profit | -5.76 | -5.17 | -5.85 |
| Net Profit Margin | -44.51 | -40.02 | -48.03 |
| Earning Per Share | -2.67 | -2.40 | -2.72 |
| EBIDTA | -2.63 | -2.16 | -2.91 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 12.94 |
| Operating Expense | 15.57 |
| Net Profit | -5.76 |
| Net Profit Margin | -44.51 |
| Earning Per Share | -2.67 |
| EBIDTA | -2.63 |
| Effective Tax Rate | TBA |
Invest in Krebs Biochemicals & Industries Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 50.42 | 52.13 | 59.70 |
| Operating Expenses Annual | 59.15 | 67.91 | 93.70 |
| Operating Profit Annual | -8.27 | -15.16 | -32.84 |
| Interest Annual | 4.69 | 2.97 | 5.39 |
| Depreciation | 6.77 | 6.56 | 6.30 |
| Net Profit Annual | -19.73 | -24.69 | -44.53 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 50.42 |
| Operating Expenses Annual | 59.15 |
| Operating Profit Annual | -8.27 |
| Interest Annual | 4.69 |
| Depreciation | 6.77 |
| Net Profit Annual | -19.73 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.09 | 0.10 | 0.71 |
| Cash Flow from Operations | 2.30 | -24.71 | -17.22 |
| Cash Flow from Investing | -7.82 | -12.65 | -22.90 |
| Cash Flow from Financing | 5.56 | 37.34 | 39.51 |
| Cash Flow at the End | 0.14 | 0.09 | 0.10 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.09 |
| Cash Flow from Operations | 2.30 |
| Cash Flow from Investing | -7.82 |
| Cash Flow from Financing | 5.56 |
| Cash Flow at the End | 0.14 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -16.40 | -29.08 | -55.01 |
| PBIT Margin (%) | -29.83 | -41.67 | -65.56 |
| PBT Margin (%) | -23.46 | -27.65 | -53.40 |
| Net PROFIT Margin (%) | -39.13 | -47.36 | -74.59 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -14.87 | -18.94 | -36.55 |
| Total Debt / Equity (X) | 2.83 | 0.78 | 2.23 |
| Asset Turnover Ratio (%) | 0.38 | 0.40 | 0.49 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -16.40 |
| PBIT Margin (%) | -29.83 |
| PBT Margin (%) | -23.46 |
| Net PROFIT Margin (%) | -39.13 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -14.87 |
| Total Debt / Equity (X) | 2.83 |
| Asset Turnover Ratio (%) | 0.38 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 151.80 | 149.16 | 140.56 |
| Total Current Assets Annual | 17.44 | 16.06 | 35.49 |
| Non Current Assets Annual | 160.73 | 158.92 | 154.31 |
| Total Shareholders Funds Annual | -119.22 | -99.46 | -75.09 |
| Total Assets Annual | 178.17 | 174.98 | 189.81 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 151.80 |
| Total Current Assets Annual | 17.44 |
| Non Current Assets Annual | 160.73 |
| Total Shareholders Funds Annual | -119.22 |
| Total Assets Annual | 178.17 |
No Data Availabe
